Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Hepatitis C

  Free Subscription


2 BMC Gastroenterol
1 J Gen Virol
2 J Hepatol
3 J Viral Hepat
1 PLoS One
1 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Gastroenterol

  1. SAKAMAKI A, Kamimura K, Fukui N, Watanabe H, et al
    A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety.
    BMC Gastroenterol. 2019;19:85.
    PubMed     Text format     Abstract available

  2. LI Y, Wang X, Yu G, Sun H, et al
    The association of hepatitis c virus infection status with serum glucose levels.
    BMC Gastroenterol. 2019;19:86.
    PubMed     Text format     Abstract available

    J Gen Virol

  3. OSAWA M, Uchida T, Imamura M, Teraoka Y, et al
    Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
    J Gen Virol. 2019 Jun 14. doi: 10.1099/jgv.0.001268.
    PubMed     Text format     Abstract available

    J Hepatol

  4. BORGIA SM, Dearden J, Yoshida EM, Shafran SD, et al
    Sofosbuvir/Velpatasvir for 12 Weeks in Hepatitis C Virus-Infected Patients with End-Stage Renal Disease Undergoing Dialysis.
    J Hepatol. 2019 Jun 10. pii: S0168-8278(19)30343.
    PubMed     Text format     Abstract available

  5. SAPENA V, Rios J, Torres F, Marino Z, et al
    Reply to: "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response".
    J Hepatol. 2019 Jun 7. pii: S0168-8278(19)30280.
    PubMed     Text format    

    J Viral Hepat

  6. DEGASPERI E, Galmozzi E, Facchetti F, Farina E, et al
    TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals.
    J Viral Hepat. 2019 Jun 8. doi: 10.1111/jvh.13155.
    PubMed     Text format     Abstract available

  7. LU M, Wu KH, Li J, Moorman AC, et al
    Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure.
    J Viral Hepat. 2019 Jun 13. doi: 10.1111/jvh.13162.
    PubMed     Text format     Abstract available

  8. RAGONNET-CRONIN M, Hostager R, Hedskog C, Osinusi A, et al
    HIV co-infection is associated with increased transmission risk in patients with chronic hepatitis C virus.
    J Viral Hepat. 2019 Jun 13. doi: 10.1111/jvh.13160.
    PubMed     Text format     Abstract available

    PLoS One

  9. PAVICIC IVELJA M, Ivic I, Dolic K, Mestrovic A, et al
    Evaluation of cerebrovascular reactivity in chronic hepatitis C patients using transcranial color Doppler.
    PLoS One. 2019;14:e0218206.
    PubMed     Text format     Abstract available

    Transplant Proc

  10. FAUST I, Weile J, Fujita B, Kandolf R, et al
    Heart Transplantation in Systemic Sclerosis: New Impulses for Conventional Scleroderma Transplantation Regimen and Scleroderma Diagnostic Monitoring: 2 Case Reports.
    Transplant Proc. 2019;51:865-870.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.